Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @LonzaPB
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LonzaPB
-
How is
#Lonza helping address#HPAPI manufacturing and containment challenges? Join us at the Highly Potent APIs Summit 2020 on 19-21 February in Prague, CZ, to learn more#nexttogether#API#ADC@Qepler https://pharma.lonza.com/events/hpapi-summit-prague …pic.twitter.com/DA8rKUkk3S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Getting your candidates from discovery to development can be complex and risky – come meet our tech experts in the US on Feb 10–14 (East Coast) & Feb 17–21 (West Coast) to talk about how we can help de-risk your candidate. Contact us today: appliedproteinservices@lonza.compic.twitter.com/Q7uExPfDiu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our latest Peer-reviewed article on the long-term stability of iPSCs authored by our Process Development team in Houston is now available on PubMed.
#iPSCs#industrializing#celltherapy#trailblazers#nexttogether https://www.ncbi.nlm.nih.gov/pubmed/31877913Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Lonza announced a clinical manufacturing agreement with@RocketPharma for their RP-L201 treatment of Leukocyte Adhesion Deficiency-I (LAD-I). This will leverage Lonza’s lentiviral vector technologies at our Houston, TX and Geleen, Netherlands cGMP sites http://bit.ly/2Rz6w2L pic.twitter.com/crEowNF38VHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How is
#Lonza addressing the growing demand for#HPAPI drug products? In an interview with@specchemmags, Maurits Janssen discussed Lonza’s focus on manufacturing flexibility and capacity to bring these molecules from concept to commercialization#ADC: http://bit.ly/38CDZ1SHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza Pharma & Biotech proslijedio/la je Tweet
BioSeedEvent was a huge success - take a look at the highlights from the event! If you missed it this year be sure not to in 2021 but don't forget there is another opportunity to showcase your company through our platform BioLaunchpad at
@biotrinity on 28/29 April in Londonpic.twitter.com/IG2LKhV9TXHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to Luk H. Vandenberghe and the team at Massachusetts Eye and Ear on this great discovery! We are proud and feel privileged to have supported such exciting research
#viralvectors#AAV#genetherapy#trailblazers#nexttogether https://www.newswise.com/articles/researchers-uncover-mechanism-for-how-common-gene-therapy-vectors-enter-cells?sc=c106 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The opportunities for commercial
#DrugDevelopment & market expansion in China are fueling tremendous growth. At the 3rd Annual#ChinaShowcase in San Francisco (CA), Rhona McIntyre, Head of Commercial Development#Lonza Biologics Guangzhou, joined an insightful panel discussion.pic.twitter.com/tHAgiUzbrr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Behnam Baghbaderani introduces the
#Lonza approach to process development and addressing the#manufacturing challenges with#cellandgene therapies in@manchempharma: http://bit.ly/2RIhqSB#celltherapy#genetherapy#processdevelopment#trailblazers#nexttogetherHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read the
@Tech_Networks interview with Lonza's Nicole Wellens, Global Product Manager for BioTherapeutics Media, and learn how our newly launched eCHO™ Feed media protect the integrity of proteins by minimizing lactate generation.https://bit.ly/2RJtG5lHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Lonza’s Charles Christy discusses what lies ahead for#bioprocessing in 2020, including single-use systems for mammalian manufacturing and hybrid processes for faster biologics manufacturing in@BioPharmIntl: http://bit.ly/38tAomRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An exciting day of
#innovative presentations yesterday at#Bioseed2020. Looking forward to next years event!https://twitter.com/OBN_UK/status/1219641075058593799 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza Pharma & Biotech proslijedio/la je Tweet
Our first showcase session of
#BioSeed2020 kindly sponsored by@lonzaPB, is just starting. We will see pitches from@carocellbio, Vidergen, Kinomica,@VitamicaAMR, Bioarchitech, Emenda Therapeutics,Reflection Therapeutics,@pHionTx and Serengenpic.twitter.com/B3WV82SM84
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza Pharma & Biotech proslijedio/la je Tweet
Thank you to
@LonzaPB for being the Cornerstone Sponsor of#BioSeed2020#Funding#Investment#StartUp#LifeSciences#Innovation#BioSeedpic.twitter.com/XnOEiVbrc2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join
#Lonza at#BioSeed2020 in London on Monday January 20th. Meet us and hear from some of the#innovative companies in#lifesciences participating. We look forward to seeing you there!https://twitter.com/BioSeedEvent/status/1214157764219621376 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza Pharma & Biotech proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Time to market for
#CellandGeneTherapy half that of other Tx (~3.5yrs) so vital to get dev right first time: Alberto Santagostino.#JPMHC20pic.twitter.com/0S5JyDGasJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lipid formulations are a simple and effective pathway to the clinic. Join our experts for this on-demand discussion. http://ow.ly/H7DI50wYI62 pic.twitter.com/ZZHnTZVa97
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Lonza looks forward to participating in#BioSeed2020 in London on January 20th. Join us for session one to hear from some of the#innovative companies participating.https://twitter.com/BioSeedEvent/status/1214157764219621376 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We were proud associate sponsors of the
@InformaConnect Cell Therapy Manufacturing and Gene Therapy Congress in Amsterdam. Behnam Ahmadian joined as a keynote speaker. Click here to listen to his presentation: https://www.youtube.com/watch?v=dXM0ijT3h-k …#nexttogether#celltherapy#genetherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.